000			01910 a2200481 4500
005			20250515235249.0
264		0	_c20101021
008			201010s 0 0 fre d
022			_a1769-6658
024	7		_a10.1016/j.canrad.2010.06.015 _2doi
040			_aNLM _beng _cNLM
100	1		_aJoly, F
245	0	0	_a[Quality of life after radiotherapy for prostate cancer]. _h[electronic resource]
260			_bCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _cOct 2010
300			_a519-25 p. _bdigital
500			_aPublication Type: English Abstract; Journal Article; Review
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAntineoplastic Agents, Hormonal _xadverse effects
650	0	4	_aBrachytherapy _xadverse effects
650	0	4	_aCombined Modality Therapy
650	0	4	_aErectile Dysfunction _xetiology
650	0	4	_aHumans
650	0	4	_aIodine Radioisotopes _xadministration & dosage
650	0	4	_aMale
650	0	4	_aPatient Acceptance of Health Care
650	0	4	_aProstatectomy _xpsychology
650	0	4	_aProstatic Neoplasms _xdrug therapy
650	0	4	_aQuality of Life
650	0	4	_aRadiation Injuries _xetiology
650	0	4	_aRadiotherapy _xadverse effects
650	0	4	_aRadiotherapy, Adjuvant _xadverse effects
650	0	4	_aRadiotherapy, Conformal _xadverse effects
650	0	4	_aRadiotherapy, Intensity-Modulated _xadverse effects
650	0	4	_aRectum _xradiation effects
650	0	4	_aSurveys and Questionnaires
650	0	4	_aTime Factors
650	0	4	_aUrinary Bladder _xradiation effects
650	0	4	_aUrination Disorders _xetiology
700	1		_aDegrendel, A-C
700	1		_aGuizard, A-V
773	0		_tCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique _gvol. 14 _gno. 6-7 _gp. 519-25
856	4	0	_uhttps://doi.org/10.1016/j.canrad.2010.06.015 _zAvailable from publisher's website
999			_c20063897 _d20063897